FILE:DVA/DVA-8K-20030717081321.txt.gz
EVENTS:	Other events	Financial statements and exhibits
TEXT:
ITEM: Other events
ITEM: Financial statements and exhibits
 
 
 
 
 
 
 
 
 
 
 
 
 
Attached hereto as Exhibit 99.1 is a press release announcing the closing of the redemption of all of the outstanding 5 5/8% Convertible Subordinated Notes due 2006 by Renal Treatment Centers, Inc., the Registrant's wholly-owned subsidiary, issued on July 15, 2003, which is incorporated by reference herein. Attached hereto as Exhibit 99.2 is a press release announcing the refinancing of the Registrant's senior credit facility issued on July 16, 2003, which is incorporated by reference herein. Attached hereto as Exhibit 99.3 is a press release announcing the call for redemption of $200,000,000 principal amount of the Registrant's 7% Convertible Subordinated Notes due 2009 issued on July 16, 2003, which is incorporated by reference herein.
 
 
(c) Exhibits
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

Exhibit 99.1
 
 
 
 
TORRANCE, CA, July 15, 2003  DaVita Inc. (NYSE: DVA) today announced that its wholly-owned subsidiary, Renal Treatment Centers, completed a call for redemption of its 5 5/8% Convertible Subordinated Notes due 2006 (the "5 5/8% Notes"). $124.7 million principal amount of 5 5/8% Notes were converted into 4,868,352 shares of DaVita common stock and $272,000 principal amount of 5 5/8% Notes were redeemed for $276,599 in cash plus accrued interest.
 
DaVita is a leading provider of dialysis services for patients suffering from chronic kidney failure. The Company owns and operates kidney dialysis centers and home peritoneal dialysis programs domestically in 33 states, as well as Washington, D.C. As of March 31, 2003, DaVita operates 523 outpatient facilities serving 45,000 patients, including 3,300 patients in 30 centers under management.

Exhibit 99.2
 
 
 
 
TORRANCE, CA, July 16, 2003  DaVita Inc. (NYSE: DVA) today announced that it has amended its senior credit facility to include additional lenders, lower interest rates and increase outstanding borrowings by $200 million. Floating interest rates on the existing Term B and new $200 million Term C portion of the amended facility are LIBOR plus 2.5% with provision for further reductions to LIBOR plus 2.25% under certain circumstances. The interest rates and outstanding borrowings ($149 million as of July 16, 2003) of the Term A and Revolving Credit Line remain unchanged. The Company also modified certain covenants and extended the weighted average maturity of the senior credit facilities from 4.4 to 4.9 years.
 
DaVita will use the $200 million of net proceeds from the Term Loan C to partially redeem its 7% Convertible Subordinated Notes due 2009. The partial redemption was announced separately today.
 
DaVita is a leading provider of dialysis services for patients suffering from chronic kidney failure. The Company owns and operates kidney dialysis centers and home peritoneal dialysis programs domestically in 33 states, as well as Washington, D.C. As of March 31, 2003, DaVita operates 523 outpatient facilities serving 45,000 patients, including 3,300 patients in 30 centers under management.
 

Exhibit 99.3
 
 
 
 
 
TORRANCE, CA, July 16, 2003  DaVita Inc. (NYSE: DVA) today announced that it is calling for redemption $200 million principal amount of its 7% Convertible Subordinated Notes due 2009 (the "7% Notes"). The aggregate principal amount outstanding of the 7% Notes is $345 million. The CUSIP number for the Notes is 89151AAA5.
 
Prior to 5:00 p.m., New York time, on August 14, 2003, holders may convert their 7% Notes into shares of DaVita common stock at a price of $32.81 per share. Any 7% Notes selected for redemption and not converted on or before 5:00 p.m., New York time, on August 14, 2003, automatically will be redeemed on August 15, 2003, and no further interest will accrue. Upon redemption, holders will receive a total of $1,042 per $1,000 principal amount of 7% Notes, plus accrued interest.
 
A Notice of Redemption is being sent to all registered holders of the 7% Notes. Copies of the Notice of Redemption may be obtained from The Bank of New York by calling 1-800-548-5075.
 
DaVita is a leading provider of dialysis services for patients suffering from chronic kidney failure. The Company owns and operates kidney dialysis centers and home peritoneal dialysis programs domestically in 33 states, as well as Washington, D.C. As of March 31, 2003, DaVita operates 523 outpatient facilities serving 45,000 patients, including 3,300 patients in 30 centers under management.


